Search - tctmd.com

Displaying 1 - 20 of 183

Sort: Relevancy | Date

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

News Daily News

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

L.A. McKeown

July 08, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

SAXOPHONE Bolsters Apixaban for Pediatric Heart Disease

Todd Neale

December 05, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Daily News

One-Third of Patients With AF After Surgery or Illness Have Recurrences

Michael O'Riordan

October 02, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

Advertisement

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Catheter Ablation for AF: Fewer Strokes, Deaths, and HF Hospitalizations

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Cardiotoxicity Rare With Common GI Chemotherapy

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Outpatient Management of Acute PE Remains Underused

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Top Endovascular News of 2023

SAXOPHONE Bolsters Apixaban for Pediatric Heart Disease

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

One-Third of Patients With AF After Surgery or Illness Have Recurrences

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content